- Home
- MRK vs BAC Comparison
MRK vs BAC Comparison
Compare MRK & BAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | BAC |
|---|---|---|
| Founded | 2000 | 1784 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 380.6B |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MRK | BAC |
|---|---|---|
| Price | $146.64 | $57.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $125.59 | $60.34 |
| AVG Volume (30 Days) | 6.4M | ★ 29.2M |
| Earning Date | 04-30-2026 | 04-15-2026 |
| Dividend Yield | ★ 3.06% | 2.12% |
| EPS Growth | 8.01 | ★ 18.69 |
| EPS | N/A | ★ 2.31 |
| Revenue | $65,011,000,000.00 | ★ $113,097,000,000.00 |
| Revenue This Year | $3.61 | $13.11 |
| Revenue Next Year | $5.41 | $5.80 |
| P/E Ratio | ★ N/A | $25.15 |
| Revenue Growth | 1.31 | ★ 11.00 |
| 52 Week Low | $77.58 | $46.12 |
| 52 Week High | $157.00 | $65.23 |
Technical Indicators
Market Signals| Indicator | MRK | BAC |
|---|---|---|
| Relative Strength Index (RSI) | 54.47 | 28.63 |
| Support Level | $145.75 | $56.84 |
| Resistance Level | $152.80 | $59.20 |
| Average True Range (ATR) | 2.64 | 1.25 |
| MACD | -1.12 | -0.58 |
| Stochastic Oscillator | 39.50 | 6.47 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About BAC Bank of America Corporation
Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.